Stock Events

Stock Events

Miravant Medical Technologies 

$0
1
+$0+0% Friday 00:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
100
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14NovExpected
Q1 2001
Q2 2001
Q3 2001
Q4 2001
Q1 2002
Q2 2002
Q3 2002
-0.29
-0.23
-0.17
-0.11
Expected EPS
-0.12
Actual EPS
-0.19

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MRVT. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Novartis is involved in the development of advanced medical therapies, which directly competes with Miravant's focus on photodynamic therapy.
Pfizer
PFE
Mkt Cap140.15B
Pfizer develops a wide range of pharmaceutical products that can compete with Miravant's treatments in various therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson offers products in multiple healthcare sectors, potentially competing in the same spaces as Miravant's technologies.
Merck
MRK
Mkt Cap214.76B
Merck produces drugs that could be alternatives to Miravant's photodynamic therapies, especially in oncology.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company develops medications that may compete with Miravant's drug development, particularly in the fields of cancer treatment.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb's extensive range of pharmaceutical products in oncology and other areas competes with Miravant's offerings.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in similar therapeutic areas, which could make them a direct competitor in the pharmaceutical market.
AMGEN
AMGN
Mkt Cap160.66B
Amgen focuses on human therapeutics, including treatments that could rival Miravant's photodynamic therapy products.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences' involvement in the pharmaceuticals market, particularly in life-threatening conditions, places them in competition with Miravant.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals develops biopharmaceutical products that could compete with Miravant's therapies in specific niche markets.

About

Miravant Medical Technologies Inc. operates as a pharmaceutical research and development company. The company develops PhotoPoint, a photodynamic therapy that responds to light destroying cancerous cells; and manufactures light producing and light delivery devices. Its products include PHOTREX for the treatment of wet age-related macular degeneration or AMD; MV9411, a photoreactive drug for the treatment of plaque psoriasis; MV0633 for the treatment of atherosclerosis, atherosclerotic vulnerable plaque, and restenosis; MV2101 for the treatment of vascular access graft disease in hemodialysis patients; and MV6401 for the treatment of solid tumors. Miravant Medical Technologies Inc. was formerly known as PDT, Inc. and changed its name to Miravant Medical Technologies Inc. in September 1997. The company was founded in 1989 and is headquartered in Santa Barbara, California.
Show more...
CEO
Mr. David E. Mai
Employees
47
Country
US
ISIN
US6046901079

Listings

0 Comments

Share your thoughts

FAQ

What is Miravant Medical Technologies stock price today?▼
The current price of MRVT is $0 USD — it has increased by +0% in the past 24 hours. Watch Miravant Medical Technologies stock price performance more closely on the chart.
What is Miravant Medical Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Miravant Medical Technologies stocks are traded under the ticker MRVT.
Is Miravant Medical Technologies stock price growing?▼
MRVT stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Miravant Medical Technologies has showed a +0% increase.
What were Miravant Medical Technologies earnings last quarter?▼
MRVT earnings for the last quarter are -0.19 USD per share, whereas the estimation was -0.12 USD resulting in a -58.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Miravant Medical Technologies have?▼
As of April 01, 2026, the company has 47 employees.
In which sector is Miravant Medical Technologies located?▼
Miravant Medical Technologies operates in the Health Care sector.
When did Miravant Medical Technologies complete a stock split?▼
Miravant Medical Technologies has not had any recent stock splits.
Where is Miravant Medical Technologies headquartered?▼
Miravant Medical Technologies is headquartered in Santa Barbara, US.